Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Theratope therapeutic vaccine: A Phase II trial

October 17, 1994 7:00 AM UTC

Biomira Inc. (BRA), Edmonton, Alberta Product: Theratope therapeutic vaccine with synthetic cancer antigens Indication: Breast and colorectal cancer Status: A Phase II trial will start in November in...